Clinical Trial

Impact of Protein Formulations on the Stimulation of Muscle Protein Synthesis

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 30, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The overall objective of this study is to determine the effects of ingesting protein that slowly releases amino acids into the blood vs. a control product on how our muscles regulate the synthesis of new proteins, termed muscle protein synthesis (MPS), in healthy volunteers.
Trial Details
NCT Number NCT07501403
Lead Sponsor VitaKey Inc.
Collaborators: United States Department of Defense, Biofortis Clinical Research, Inc.
Conditions Nutrition
Enrollment 20 participants
Start Date 2026-04
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-03-30